Health system costs of treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid in different settings

Mayara Lisboa Bastos, Jonathon R. Campbell, Olivia Oxlade, Menonli Adjobimey, Anete Trajman, Rovina Ruslami, Hee Jin Kim, Joseph Obeng Baah, Brett G. Toelle, Richard Long, Vernon Hoeppner, Kevin Elwood, Hamdan Al-Jahdali, Lika Apriani, Andrea Benedetti, Kevin Schwartzman, Dick Menzies*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Health system costs of treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid in different settings'. Together they form a unique fingerprint.

Medicine & Life Sciences